News

Zephyr Valve Led to Sustained Benefits in Homogeneous Emphysema

The Zephyr Endobronchial Valve leads to sustained and significant improvements in lung function, exercise capacity, and quality of life in people with homogeneous emphysema, a severe form of chronic obstructive pulmonary disease (COPD), according to one-year data from the IMPACT clinical study. “This is very important data because…

Protein Implicated in Emphysema May Be Potential Therapeutic Target

Mice lacking a protein called FCHSD1 were protected from developing emphysema, a severe form of chronic obstructive pulmonary disease (COPD), according to data from a recent study. Based on these observations, researchers say this protein could serve as a future therapeutic target for COPD. “Our findings may also lead…

Study Pushes for Better Dental Care in Brazil for COPD Patients

Dental care in Brazil needs to be more accessible to patients with chronic obstructive pulmonary disease (COPD) and integrated into their primary care to better tackle the impact of the disease in the country, a study suggests. “Our research indicates that incorporating preventative oral health into COPD management and…

Platelet-based Therapy May Slow Lung Function Decline

Treatment with PRP-PC, an investigational platelet-based cellular therapy, may slow the decline in lung function typically experienced by people with chronic obstructive pulmonary disease (COPD), a new study with real-world data indicates. With this therapy, being developed by H-CYTE, a person’s own blood is treated in the lab…

Preventing Certain Type of Cell Death May Help Treat COPD

Preventing a specific type of cell death, called necroptosis, may provide a new way of treating chronic obstructive pulmonary disease (COPD), according to data from a recent study. Patients with COPD have elevated levels of necroptosis, the study revealed. Stopping that type of cell death leads to significant reductions…